mr. ronazizzi. itch i could a if i could ask you a few questions. what reg laotilationship does d to have manufacturers avoid drug diversion? >> for starters, pharmacists are held pretty much to the same standard that doctors are under 1306.04. 1306.04 says a prescription is not valid unless issued for legitimate medical purpose unusual course of medical practice. it goes on to say a corresponding responsibility exists with te pharmacist to ensure the prescription is valid. the manufacturer is under 1301.71 and 1301.74 have to maintain a system that -- that stops diversion. or the diversion of controlled substances into other than a legitimate marketplace. it also goes on to say that you also have a, have to maintain a system of suspicious ordering monitoring. and -- they leave it up to the manufacturers and distributors to determine how to set up that, that system, of suspicious ordering, monitoring. >> right. you know, i know, dea has ability to see unusual ordering patterns. are there certain thresh holds or levels that you pass on to the distrib

mr. butter field for five minutes. >> thank you. let me -- go to the -- to the gentleman from the dea. how do you pronounce your name? ronazizzi. >> ronazizzi. all right. thank you. let me talk with you about the security procedures followed by the prescription drug manufacturers, specifically, how the drug moves from raw materials to usable med sun then to distributors and then done to the wholesalers. are you comfortable, sir, with the security mechanisms ep ployploy -- employed by the come snaenz. >> physical security systems for the most part i am. we do onsite inspections every three years or so for manufacturers. importers/exporters, raw material holders. if there is problems in the physical security we handle it onsite. we make suggestions. and -- generally it is correct the. >> right. what kind of relationship does the dea have with -- with the prescription drug industry, specifically what programs does dea employ to educate dea manufacturers and distributors? how closely, if at all, and does dea audit or prove security measures employed by the manufacturers and distributors? and, is there a difference in procedure, fo